[
    [
        {
            "time": "2020-11-17",
            "original_text": "成都威斯克公司A轮融资近3亿元用于疫苗研发",
            "features": {
                "keywords": [
                    "威斯克",
                    "融资",
                    "疫苗",
                    "研发"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "成都威斯克公司A轮融资近3亿元用于疫苗研发",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-11-17",
            "original_text": "海外疫情催生医药商业龙头外贸突破 世界健博会线上交易平台启动",
            "features": {
                "keywords": [
                    "海外疫情",
                    "医药商业",
                    "外贸",
                    "交易平台"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "外贸"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "海外疫情催生医药商业龙头外贸突破 世界健博会线上交易平台启动",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-11-17",
            "original_text": "疫苗研发生产和免疫治疗公司威斯克生物获3亿人民币战略融资",
            "features": {
                "keywords": [
                    "威斯克生物",
                    "融资",
                    "疫苗",
                    "研发",
                    "免疫治疗"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "疫苗研发生产和免疫治疗公司威斯克生物获3亿人民币战略融资",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-17",
            "original_text": "威斯克生物完成3亿人民币战略融资",
            "features": {
                "keywords": [
                    "威斯克生物",
                    "融资",
                    "战略"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "威斯克生物完成3亿人民币战略融资",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2020-11-17",
            "original_text": "我国首个利用昆虫细胞研发的重组蛋白新冠疫苗进入二期临床",
            "features": {
                "keywords": [
                    "重组蛋白疫苗",
                    "二期临床",
                    "研发",
                    "新冠"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "我国首个利用昆虫细胞研发的重组蛋白新冠疫苗进入二期临床",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2020-11-17",
            "original_text": "医药行业机遇和挑战并存，部分板块仍具备结构性机会",
            "features": {
                "keywords": [
                    "医药行业",
                    "机遇",
                    "挑战",
                    "结构性机会"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "医药行业机遇和挑战并存，部分板块仍具备结构性机会",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        }
    ]
]